Vuokko Nummi (V Nummi)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Ejection Fraction

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

International journal of laboratory hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Vuokko Nummi, Leena Hiltunen, Timea Szanto, Eira Poikonen, Anna-Elina Lehtinen
Acquired haemophilia A in Finland: A nationwide study of incidence, treatment and outcomes. Haemophilia : the official journal of the World Federation of Hemophilia (2024)
Kristina Kihlberg, Fariba Baghaei, Maria Bruzelius, Eva Funding, Pål Andre Holme, Riitta Lassila, Vuokko Nummi, Susanna Ranta, Nadine G Andersson, Erik Berntorp, Jan Astermark
No difference in quality of life between persons with severe haemophilia A and B. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Ragnhild J Måseide, Erik Berntorp, Jan Astermark, Anna Olsson, Maria Bruzelius, Tony Frisk, Vuokko Nummi, Riitta Lassila, Geir E Tjønnfjord, Pål A Holme
Health-related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study). Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Vuokko Nummi, Anna-Elina Lehtinen, Alfonso Iorio, Timea Szanto, Riitta Lassila
Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics. Haemophilia : the official journal of the World Federation of Hemophilia 28 (6) (2022)
Ragnhild J Måseide, Erik Berntorp, Jan Astermark, Jessica Hansen, Anna Olsson, Maria Bruzelius, Tony Frisk, Magnus Aspdahl, Vuokko Nummi, Geir E Tjønnfjord, Pål A Holme
Haemophilia early arthropathy detection with ultrasound and haemophilia joint health score in the moderate haemophilia (MoHem) study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (2) (2021)
Kristina Kihlberg, Fariba Baghaei, Maria Bruzelius, Eva Funding, Pål Andre Holme, Riitta Lassila, Vuokko Nummi, Susanna Ranta, Mehdi Osooli, Erik Berntorp, Jan Astermark
Treatment outcomes in persons with severe haemophilia B in the Nordic region: The B-NORD study. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Ragnhild J Måseide, Erik Berntorp, Vuokko Nummi, Riitta Lassila, Geir E Tjønnfjord, Pål A Holme
Bleeding phenotype of patients with moderate haemophilia A and B assessed by thromboelastometry and thrombin generation. Haemophilia : the official journal of the World Federation of Hemophilia 27 (5) (2021)
Ragnhild J Måseide, Erik Berntorp, Jan Astermark, Anna Olsson, Maria Bruzelius, Tony Frisk, Vuokko Nummi, Riitta Lassila, Geir E Tjønnfjord, Pål A Holme
Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study. Haemophilia : the official journal of the World Federation of Hemophilia 26 (5) (2020)
Vuokko Nummi, Elina Lehtinen, Anne Mäkipernaa, Timea Szanto, Riitta Lassila
Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed. Haemophilia : the official journal of the World Federation of Hemophilia 25 (4) (2019)
Vuokko Nummi, R Lassila, L Joutsi-Korhonen, E Armstrong, T Szanto
Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function. International journal of laboratory hematology 40 (3) (2018)
Vuokko Nummi, A Jouppila, R Lassila
Monitoring once-weekly recombinant factor IX prophylaxis in hemophilia B with thrombin generation assay and factor IX activity. International journal of laboratory hematology 39 (4) (2017)